Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurology

• Publication date

  2009-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.WNL.0000344302.64570.97
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF ATORVASTATIN IN ELDERLY PATIENTS WITH A RECENT STROKE OR TRANSIENT ISCHEMIC ATTACK

  2009cited by this paper
• SUBTHALAMIC NUCLEUS AND ITS CONNECTIONS: ANATOMIC SUBSTRATE FOR THE NETWORK EFFECTS OF DEEP BRAIN STIMULATION

  2009cited by this paper
• Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy

  2008cited by this paper
• Patterns of Guillain-Barré syndrome in children: Results from a Mexican population

  2008cited by this paper
• Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

  2008cited by this paper
• Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study

  2008cited by this paper
• Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study

  2007cited by this paper
• High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

  2007cited by this paper
• Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the

  2006cited by this paper
• Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

  2005cited by this paper
• Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal.

  2004cited by this paper
• Teratogenicity of anticonvulsant drugs.

  1985cited by this paper

• Medication use during pregnancy and birth defects in Hunan province, China, during 2016–2019: A cross-sectional study

  2022cites this paper
• Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review

  2021cites this paper
• Risk of Medication Exposures in Pregnancy and Lactation

  2021cites this paper
• Biological Properties Study Of Two New Benzylpencillin Derivatives

  2021cites this paper
• Lack of psychotropic medication changes among mood disordered women across the peripartum period

  2021cites this paper
• Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications

  2021cites this paper
• The Modern Approach To The Management Of Pregnancy And Childbirth In Women With Epilepsy

  2020cites this paper
• Maternal Risk Factors Associated With The Development Of Cleft Lip And/Or Palate In Sudan

  2019cites this paper
• Women with Epilepsy: Anti-epileptic Drugs and Perinatal Outcomes

  2019cites this paper
• Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries

  2019cites this paper
• Neurology and Psychiatry of Women

  2019cites this paper
• A COMPARATIVE STUDY OF THE TERATOGENIC EFFECTS OF ANTIEPILEPTIC DRUGS: LAMOTRIGINE AND LEVETIRACETAM ON ADULT ALBINO RATS

  2019cites this paper
• Evaluation of Teratogenic Activity of Antiepileptic Drug Lamotrigine in Mouse Fetuses

  2019cites this paper
• Weighing the Risks: the Management of Bipolar Disorder During Pregnancy

  2018cites this paper
• Use of Psychotropic Medications Among Pregnant Women with Bipolar Disorder: Patterns, Determinants, and Impact on Perinatal Outcomes

  2018cites this paper
• Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies

  2017cites this paper
• Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis

  2017cites this paper
• Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression

  2017influential citation
• Fetal growth and premature delivery in pregnant women on antiepileptic drugs

  2017cites this paper
• A systematic review of pregnancy exposure registries: examination of protocol‐specified pregnancy outcomes, target sample size, and comparator selection

  2017cites this paper
• Predictors of unintended pregnancy in women with epilepsy

  2017cites this paper
• Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study.

  2017influential citation
• A New-born with Severe Hydrocephalus and Myelomeningocele Associated with Maternal Antiepileptic Medication: A Case Report

  2017cites this paper
• Pregnant Women with Epilepsy: Management Issues

  2017cites this paper
• Teratogenicity and perinatal outcomes associated with epilepsy and the use of antiepileptic drugs

  2017cites this paper
• How Should Antiepileptic Drugs Be Selected During Pregnancy

  2017cites this paper
• Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies

  2016cites this paper
• Antiepileptic drugs in pregnancy

  2016cites this paper
• Management of women with epilepsy: from preconception to post-partum

  2016cites this paper
• Psychopharmacotherapy in Pregnancy and Breastfeeding

  2016cites this paper
• Antiepileptic drug combinations not involving valproate and the risk of fetal malformations

  2016cites this paper
• The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review

  2016cites this paper
• Bipolar disorder: a review of current U.S. Food and Drug Administration approved pharmacotherapy

  2015cites this paper
• Foetal safety of old and new antiepileptic drugs

  2015cites this paper
• Risk factors involved in orofacial cleft predisposition – review

  2015cites this paper
• Major congenital malformations in children of women with epilepsy.

  2015cites this paper
• Psychotropes et grossesse : mise en place d'un suivi th erapeutique au sein du r eseau M ere-Enfant du Centre

  2015cites this paper
• Epilepsy and women

  2015cites this paper
• The Selection and Use of Essential Medicines.

  2015cites this paper
• Bipolar Disorder in Women

  2015cites this paper
• Use of psychotropic drugs during pregnancy and breast‐feeding

  2015cites this paper
• Epilepsy in Adolescents: Rational Treatment and Considerations

  2015cites this paper
• Epilepsy and antiepileptic medications

  2015cites this paper
• Mood stabilizers in pregnancy and lactation

  2015cites this paper
• Association Between Topiramate and Zonisamide Use During Pregnancy and Low Birth Weight

  2014cites this paper
• Otorhinolaryngology/maxillofacial disorders

  2014cites this paper
• Anticonvulsants Teratogenic Mechanism Involves Alteration of Bioelectrically-controlled Processes in the Embryo. A hypothesis

  2014cites this paper
• Managing the side effects associated with commonly used treatments for bipolar depression.

  2014cites this paper
• Diagnosis and management of bipolar disorder in primary care: a DSM-5 update.

  2014cites this paper
• The Use of Central Nervous System Active Drugs During Pregnancy

  2013cites this paper
• Are Newer Antiepileptic Drugs Associated with Improved Safety in Pregnancy Compared to Older Antiepileptic Drugs?

  2013cites this paper
• Spezielle Arzneimitteltherapie in der Schwangerschaft

  2013influential citation
• Lamotrigine use in pregnancy

  2012cites this paper
• Die Behandlung mit Psychopharmaka in der Schwangerschaft – Teil I : So wenig wie möglich , aber so viel wie nötig Treatment with Psychopharmaca During Pregnancy – Part I : As Little as Possible but as Much as Necessary

  2012cites this paper
• Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings

  2012cites this paper
• Management of Newly Diagnosed Epilepsy

  2012cites this paper
• The general practice research database as an alternative to registries for studying drug safety in pregnancy: Anticonvulsants as a case study

  2012cites this paper
• Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

  2012cites this paper
• Antiepileptic drugs and pregnancy outcomes

  2012cites this paper
• Comparative safety of antiepileptic drugs during pregnancy

  2012cites this paper
• Psychopharmaka in Schwangerschaft und Stillzeit

  2012cites this paper
• Neurobehavioral Consequences of Prenatal Antiepileptic Drug Exposure

  2012cites this paper
• Antiepileptic Drugs during Pregnancy in Primary Care: A UK Population Based Study

  2012cites this paper
• Die Behandlung mit Psychopharmaka in der Schwangerschaft – Teil I: So wenig wie möglich, aber so viel wie nötig

  2012cites this paper
• Systematic overview of data sources for drug safety in pregnancy research

  2012cites this paper
• Drug treatment for mood disorders in pregnancy

  2011cites this paper
• Teratogenic exposures

  2011cites this paper
• Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States

  2011cites this paper
• Use of antiepileptic medications in pregnancy in relation to risks of birth defects.

  2011cites this paper
• Health technology assessment in maternal and perinatal medicine : delphi survey of practice, systematic reviews of evidence and meta analyses

  2011cites this paper
• Babies exposed to newer-generation antiepileptic drugs (compared with no antiepileptic drug exposure) in the first-trimester of pregnancy are not at increased risk of major birth defects

  2011cites this paper
• Risk assessment of antiepileptic drugs in pregnancy

  2011cites this paper
• Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

  2011cites this paper
• Newer-generation antiepileptic drugs and the risk of major birth defects.

  2011cites this paper
• Fehlbildungsrisiko bei Antiepileptika

  2010cites this paper
• Mood Stabilizers in Pregnancy: A Systematic Review

  2010cites this paper
• [The treatment of bipolar disorder during pregnancy and the postpartum period].

  2010influential citation
• Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy

  2010cites this paper
• Antiepileptic drug pregnancy registries: do the latest findings concur?

  2010cites this paper
• Pregnancy registries: Differences, similarities, and possible harmonization

  2010cites this paper
• Effect of prenatal levetiracetam exposure on motor and cognitive functions of rat offspring.

  2010cites this paper
• Teratogenic effects of antiepileptic drugs

  2010cites this paper
• Lamotrigine in pregnancy

  2010cites this paper
• WOMEN'S ISSUES AND EPILEPSY

  2010cites this paper
• Antiepileptic drug use in women of childbearing age.

  2009cites this paper
• Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

  2009cites this paper
• Use of Clonazepam and Avoidance of Sleep Deprivation in the Treatment of Juvenile Myoclonic Epilepsy

  2009cites this paper
• Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET‐2)

  2009cites this paper
• INCREASED FREQUENCY OF ISOLATED CLEFT PALATE IN INFANTS EXPOSED TO LAMOTRIGINE DURING PREGNANCY

  2009cites this paper
• Kontrazeption und Schwangerschaft bei Frauen mit Epilepsie - Eine Stellungnahme der DGGEF

  2009cites this paper
• Women and epilepsy.

  2009cites this paper
• The management of epilepsy in pregnancy

  2009cites this paper
• The first line of therapy in a girl with juvenile myoclonic epilepsy: Should it be valproate or a new agent?

  2009cites this paper
• Pregnancy, delivery, and outcome for the child in maternal epilepsy

  2009cites this paper
• Treating women with juvenile myoclonic epilepsy

  2009cites this paper
• Preventing Excessive Weight Gain During Pregnancy Through Dietary and Lifestyle Counseling : A Randomized Controlled Trial

  2009cites this paper
• Prospective surveillance of Croatian pregnant women on lamotrigine monotherapy--aspects of pre-pregnancy counseling and drug monitoring.

  2009cites this paper
• Pregnancy and epilepsy: what should we tell our patients?

  2009cites this paper
• Epilepsy in Pregnancy

  2009cites this paper
• Family history of congenital malformations in women with e associated with a two to three fold increase in the risk of fetal malformations

  2008cites this paper